Koers Optima Medical Innovations Corp. Canadian Securities Exchange
Aandelen
TOKI
CA68405M1095
Farmaceutische producten
Omzet 2019 | 5,37 mln. 7,32 mln. 4,94 mln. | Omzet 2020 | 4,61 mln. 6,29 mln. 4,24 mln. | Marktkapitalisatie | 1,8 mln. 2,45 mln. 1,65 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -17 mln. -23,17 mln. -15,64 mln. | Nettowinst (verlies) 2020 | -3 mln. -4,09 mln. -2,76 mln. | EV/omzet 2019 | 1,58 x |
Nettoschuld 2019 | 2,19 mln. 2,98 mln. 2,01 mln. | Nettoschuld 2020 | 1,24 mln. 1,69 mln. 1,14 mln. | EV/omzet 2020 | 0,66 x |
K/w-verhouding 2019 |
-0,35
x | K/w-verhouding 2020 |
-0,44
x | Werknemers | 9 |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,35% | 705 mld. | |
+30,88% | 583 mld. | |
-3,49% | 364 mld. | |
+20,15% | 332 mld. | |
+6,19% | 291 mld. | |
+15,55% | 238 mld. | |
-3,19% | 210 mld. | |
+10,43% | 209 mld. | |
+9,21% | 169 mld. |